Effects of sinomenine on proliferation and apoptosis in human lung cancer cell line NCI-H460 in vitro

Molecular Medicine Reports

Volumn 3, Issue 1, 2010, Pages 51-56

  Jiang, Tingshu ^a   Zhou, Liping ^a   Zhang, Wenlu ^a   Qu, Dan ^a   Xu, Xiaoman ^a   Yang, Ying ^b   Li, Shengqi ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; NCI H460 lung cancer cell line; Sinomenine

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; PROTEIN BAX; PROTEIN BCL 2; SINOMENINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN SECRETION;

EID: 76149136380     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr-00000217     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun M: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
2. Erridge S, Moller H, Price A and Brewster D: International comparisons of survival from lung cancer: pitfalls and warnings. Nat Clin Pract Oncol 4: 570-577, 2007.
3. Yamasaki H: Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomeniun acutum. Acta Med Okayama 30: 1-20, 1976.
4. Qian L, Xu Z, Zhang W, Wilson B, Hong JS and Hood PM: Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase. J Neuroinflammation 4: 23-37, 2007.
5. Liu L, Buchner E, Beitze D, et al: Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. Int J Immunopharmacol 18: 529-543, 1996.
6. Zhou H, Wong Y, Wang J, Cai X and Liu L: Sinomenine ameliorates arthritis via MMPs, TIMPs and cytokines in rats. Biochem Biophys Res Commun 376: 352-357, 2008.
7. Wang M, Chang C, Cheng J, Wu H, Li Y and Cheng J: Activation of opioid mu-receptor by sinomenine in cell and mice. Neurosci Lett 443: 209-212, 2008.
8. Xu S, Shen X, Li Z, Wu B and Jang C: On the mechanism of sinomenine 'analgesia'. Sheng Li Xue Bao 27: 281-291, 1964.
9. Zhao D, Yang X, Li Z and Sheng B: Antiantythmic effects of sinomenine hydrochloride. Yao Xue Xue Bao 20: 856-858, 1985.
10. Kok T, Yue P, Mak N, Fan T, Liu L and Wong R: The anti-angiogenic effect of sinomeninc. Angiogenesis 8: 3-12, 2005.
11. Li L, Gao X and Ding B: Inhibitory effect of sinomenine on H202-induced apoptosis in neonatal rat cardiomyocytes. Zhongguo Zhong Yao Za Zhi 33: 939-941, 2008.
12. He X, Wang J, Guo Z, et al: Requirement for ERK activation in sinomenine-induced apoptosis of macrophages. Immunol Lett 98: 91-96, 2005.
13. Li X, Yue P, Ha W, et al: Effect of sinomenine on gene expression of the IL-1 beta-activated human synovial sarcoma. Life Sci 79: 665-673, 2006.
14. Gong L and Gao Y: Apoptotic derivation of hepatoma carcinoma cell by kukoline. J Chengdu Univ Tradit Chin Med 30: 38-39, 2007.
15. Mehmet H: Caspases find a new place to hide. Nature 403: 29-30, 2000.
16. De Maria R, Lenti L, Malisan F, et al: Requirement for GD3 ganglioside in CD95 and ceramide-induced apoptosis. Science 277: 1652-1655, 1997.
17. Nakagawa T, Zhu H, Morishima N, et al: Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid beta. Nature 403: 98-103, 2000.
18. Herbst R, Heymach J and Lippman S: Lung cancer. N Engl J Med 359: 1367-1380, 2008.
19. Kasibhatla S and Tseng B: Why target apoptosis in cancer treatment? Mol Cancer Ther 2: 573-580, 2003.
20. Waxman D and Schwartz P: Harnessing apoptosis for improved anticancer gene therapy. Cancer Res 63: 8563-8572, 2003.
21. Hengartner M: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
22. Hsu H, Houng J, Kuo C, Tsao N and Wu Y: Glossogin, a novel phenylpropanoid from Glossogyne tenuifolia, induced apoptosis in A549 lung cancer cells. Food Chem Toxicol 46: 3785-3791, 2008.
23. Magesh V, Lee J, Ahn K, et al: Ocimum sanctum induces apoptosis in A549 lung cancer cells and suppresses the in vivo growth of lewis lung carcinoma cells. Phytother Res: Mar, 2009 (E-pub ahead of print).
24. Certo M, Del Gaizo Moore V, Nishino M, et al: Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 9: 328-330,2006.
25. Lanave C, Santamaria M and Saccone C: Comparative genomics: the evolutionary history of the Bcl-2 family. Gene 333: 71-79, 2004.
26. Papadopoulos K: Targeting the Bcl-2 family in cancer therapy. Semin Oncol 33: 449-456, 2006.